ANXA2 and Alzheimer disease: ATP fluorescent assays showed that AnxA2 knockdown significantly reduced ATP levels in the AD cell model (Figure 9), indicating that AnxA2 may regulate energy metabolism through the modulation of mitochondrial function or glucose metabolism pathways [67].